Evidence map›Paper›PMID 35365139›Full record

Trial reportBMC health services research2022

Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD.

Kate K Watabayashi, Ari Bell-Brown, Karma Kreizenbeck, Kathryn Egan, Gary H Lyman, Dawn L Hershman, Kathryn B Arnold, Aasthaa Bansal, William E Barlow, Sean D Sullivan and 1 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02728596 (A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02728596 nacompletednot on this map

A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

TypeinterventionalSponsorSWOG Cancer Research NetworkRan2016 to 2021Enrolled3,665ConditionsFebrile Neutropenia, Stage 0 Breast Cancer, Stage 0 Colorectal Cancer, Stage 0 Non-Small Cell Lung CancerArmsPreventive Intervention, Quality-of-Life Assessment, Questionnaire Administration
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Kate K WatabayashiFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA. kwatabay@fredhutch.org.
Ari Bell-BrownFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Karma KreizenbeckFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Kathryn EganAmazon, 410 Terry Ave N., Seattle, WA, 98109, USA.
Gary H LymanFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Dawn L HershmanColumbia University Medical Center, 161 Ft. Washington 1068, New York, NY, 10032, USA.
Kathryn B ArnoldFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Aasthaa BansalFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
William E BarlowFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Sean D SullivanFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Scott D RamseyFred Hutchinson Cancer Research Center, 1100 Fairview Ave N. PO Box 19024, Seattle, WA, 98109, USA.
Fred Hutch Cancer Center · USSeattle University · USAmazon (United States) · USColumbia University Irving Medical Center · USSWOG Cancer Research Network · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
NCI NIH HHS P30 CA015704NCI NIH HHS UG1 CA189974Patient-Centered Outcomes Research Institute PCS-1402-09988
6 · The paper itself

Abstract

backgroundCancer Care Delivery (CCD) research studies often require practice-level interventions that pose challenges in the clinical trial setting. The SWOG Cancer Research Network (SWOG) conducted S1415CD, one of the first pragmatic cluster-randomized CCD trials to be implemented through the National Cancer Institute (NCI) Community Oncology Program (NCORP), to compare outcomes of primary prophylactic colony stimulating factor (PP-CSF) use for an intervention of automated PP-CSF standing orders to usual care. The introduction of new methods for study implementation created challenges and opportunities for learning that can inform the design and approach of future CCD interventions.

methodsThe order entry system intervention was administered at the site level; sites were affiliated NCORP practices that shared the same chemotherapy order system. 32 sites without existing guideline-based PP-CSF standing orders were randomized to the intervention (n = 24) or to usual care (n = 8). Sites assigned to the intervention participated in tailored training, phone calls and onboarding activities administered by research team staff and were provided with additional funding and external IT support to help them make protocol required changes to their order entry systems.

resultsThe average length of time for intervention sites to complete reconfiguration of their order sets following randomization was 7.2 months. 14 of 24 of intervention sites met their individual patient recruitment target of 99 patients enrolled per site.

conclusionsIn this paper we share seven recommendations based on lessons learned from implementation of the S1415CD intervention at NCORP community oncology practices representing diverse geographies and patient populations across the U. S. It is our hope these recommendations can be used to guide future implementation of CCD interventions in both research and community settings.

trial registrationNCT02728596 , registered April 5, 2016.

Indexed as

Delivery of Health CareNeoplasmsHealth Services ResearchHumansCancer care deliveryCluster-randomizedColony stimulating factorComputerized clinical decision support systemIntervention

Identifiers

PMID35365139
PMCPMC8973954
OpenAlexW4220788913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.